Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 31% ± 13% | |
endothelial cell | 7 studies | 24% ± 5% | |
ciliated cell | 7 studies | 26% ± 7% | |
fibroblast | 7 studies | 24% ± 7% | |
oligodendrocyte | 7 studies | 21% ± 5% | |
smooth muscle cell | 6 studies | 17% ± 1% | |
pericyte | 5 studies | 20% ± 5% | |
epithelial cell | 5 studies | 24% ± 5% | |
retina horizontal cell | 4 studies | 22% ± 3% | |
Mueller cell | 4 studies | 21% ± 2% | |
glutamatergic neuron | 4 studies | 24% ± 9% | |
endothelial cell of lymphatic vessel | 4 studies | 18% ± 2% | |
glial cell | 3 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 26% ± 7% | |
ependymal cell | 3 studies | 27% ± 11% | |
myofibroblast cell | 3 studies | 19% ± 5% | |
Schwann cell | 3 studies | 26% ± 10% | |
adipocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2610.96 | 1445 / 1445 | 100% | 36.56 | 183 / 183 |
ovary | 100% | 4685.67 | 180 / 180 | 100% | 50.61 | 430 / 430 |
prostate | 100% | 2267.57 | 245 / 245 | 100% | 23.23 | 502 / 502 |
skin | 100% | 3195.23 | 1809 / 1809 | 100% | 47.01 | 472 / 472 |
uterus | 100% | 3998.26 | 170 / 170 | 100% | 34.78 | 458 / 459 |
breast | 100% | 2690.74 | 459 / 459 | 100% | 36.77 | 1115 / 1118 |
lung | 100% | 1919.12 | 577 / 578 | 100% | 32.68 | 1152 / 1155 |
intestine | 100% | 2275.43 | 965 / 966 | 99% | 25.92 | 524 / 527 |
bladder | 100% | 2335.95 | 21 / 21 | 99% | 25.71 | 498 / 504 |
thymus | 100% | 2359.78 | 653 / 653 | 99% | 26.81 | 597 / 605 |
stomach | 99% | 1875.43 | 355 / 359 | 100% | 27.42 | 285 / 286 |
adrenal gland | 100% | 2244.38 | 258 / 258 | 97% | 18.77 | 223 / 230 |
brain | 97% | 1367.71 | 2555 / 2642 | 100% | 31.82 | 704 / 705 |
kidney | 100% | 2104.55 | 89 / 89 | 96% | 40.19 | 867 / 901 |
pancreas | 93% | 736.84 | 306 / 328 | 98% | 24.55 | 175 / 178 |
liver | 83% | 628.64 | 188 / 226 | 79% | 13.02 | 320 / 406 |
adipose | 100% | 2674.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2914.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 71.77 | 80 / 80 |
spleen | 100% | 1324.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 36.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.82 | 1 / 1 |
muscle | 91% | 764.39 | 733 / 803 | 0% | 0 | 0 / 0 |
heart | 88% | 1150.20 | 760 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 8.01 | 20 / 29 |
peripheral blood | 21% | 202.53 | 195 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061512 | Biological process | protein localization to cilium |
GO_0060831 | Biological process | smoothened signaling pathway involved in dorsal/ventral neural tube patterning |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0021953 | Biological process | central nervous system neuron differentiation |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0060434 | Biological process | bronchus morphogenesis |
GO_0001843 | Biological process | neural tube closure |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0031076 | Biological process | embryonic camera-type eye development |
GO_0048702 | Biological process | embryonic neurocranium morphogenesis |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0007420 | Biological process | brain development |
GO_0061548 | Biological process | ganglion development |
GO_0060348 | Biological process | bone development |
GO_0005730 | Cellular component | nucleolus |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0097731 | Cellular component | 9+0 non-motile cilium |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005930 | Cellular component | axoneme |
GO_0005929 | Cellular component | cilium |
GO_0097546 | Cellular component | ciliary base |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0120160 | Molecular function | intraciliary transport particle A binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TULP3 |
Protein name | TUB like protein 3 Tubby-related protein 3 (Tubby-like protein 3) |
Synonyms | TUBL3 |
Description | FUNCTION: Negative regulator of the Shh signaling transduction pathway: recruited to primary cilia via association with the IFT complex A (IFT-A) and is required for recruitment of G protein-coupled receptor GPR161 to cilia, a promoter of PKA-dependent basal repression machinery in Shh signaling. Binds to phosphorylated inositide (phosphoinositide) lipids. Both IFT-A- and phosphoinositide-binding properties are required to regulate ciliary G protein-coupled receptor trafficking. During adipogenesis, regulates ciliary trafficking of FFAR4 in preadipocytes. . |
Accessions | ENST00000397132.6 [O75386-2] F5H7B9 H0YG12 ENST00000538354.5 ENST00000541678.5 H0YFU8 ENST00000545331.5 O75386 ENST00000540184.5 [O75386-3] F5GWL5 ENST00000538704.1 ENST00000448120.7 [O75386-1] ENST00000544943.5 |